Ion channel modulation as a drug discovery target in inflammatory diseases
Inflamm Res
.
1996 Sep;45(9):435-7.
doi: 10.1007/BF02252312.
Authors
D C Hanson
1
,
K Koch
Affiliation
1
Central Research Division, Pfizer Inc., Groton, CT 06340, USA.
PMID:
8891752
DOI:
10.1007/BF02252312
No abstract available
Publication types
Congress
MeSH terms
Animals
Anti-Inflammatory Agents / pharmacology*
Humans
Inflammation / drug therapy*
Ion Channels / drug effects*
Substances
Anti-Inflammatory Agents
Ion Channels